India too should look into mixed dose regime trial, says NITI Aayog member 
If proven effective it could go a long way in enhancing faster coverage, says NITI Aayog member
Health Vk Paul Working Group National Technical Advisory Group Lockdown Extension Single Day Spik E Covid 19 Vaccine
Source: thehindu.com